The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticlesXiu-Chai Zheng, Xuan Zhang, Man Liu et al.|International Journal of Nanomedicine|2018Cited by 98
Effect of XlogP and Hansen Solubility Parameters on Small Molecule Modified Paclitaxel Anticancer Drug Conjugates Self-Assembled into NanoparticlesTing Zhong, Xuan Zhang, Yanli Hao et al.|Bioconjugate Chemistry|2018Cited by 27
Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivoMeiqi Xu, Xuan Zhang, Yanli Hao et al.|International Journal of Nanomedicine|2021Cited by 19
Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivoXiao-Chuan Duan, Xuan Zhang, Xin Yao et al.|International Journal of Nanomedicine|2018Cited by 8
Methyl-β-cyclodextrin Enhances Tumor Cellular Uptake and Accumulation of α-Linolenic Acid–Paclitaxel Conjugate NanoparticlesM. Xu, Xuan Zhang, Jianming Yu et al.|Molecular Pharmaceutics|2024Cited by 7